Antibiotic Prophylaxis for Simple Hand Lacerations
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01155154 |
Recruitment Status :
Terminated
First Posted : July 1, 2010
Results First Posted : November 4, 2014
Last Update Posted : November 7, 2014
|
Sponsor:
State University of New York - Downstate Medical Center
Collaborators:
Staten Island University Hospital
Kings County Hospital Center
Information provided by (Responsible Party):
Shahriar Zehtabchi, State University of New York - Downstate Medical Center
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Tracking Information | ||||
---|---|---|---|---|
First Submitted Date ICMJE | June 29, 2010 | |||
First Posted Date ICMJE | July 1, 2010 | |||
Results First Submitted Date ICMJE | January 3, 2014 | |||
Results First Posted Date ICMJE | November 4, 2014 | |||
Last Update Posted Date | November 7, 2014 | |||
Study Start Date ICMJE | February 2010 | |||
Actual Primary Completion Date | February 2012 (Final data collection date for primary outcome measure) | |||
Current Primary Outcome Measures ICMJE |
Number of Participants With Presence of Wound Infection [ Time Frame: 2 weeks ] Hand lacerations will be examined 10-14 days after initial wound closure and will be assessed for presence of infection.
|
|||
Original Primary Outcome Measures ICMJE |
Wound Infection [ Time Frame: 2 weeks ] Hand lacerations will be examined 10-14 days after initial wound closure and will be assessed for presence of infection.
|
|||
Change History | ||||
Current Secondary Outcome Measures ICMJE | Not Provided | |||
Original Secondary Outcome Measures ICMJE |
Risk of side effects from antibiotics [ Time Frame: 2 weeks ] Subjects will be examined and questioned in order to identify any signs or symptoms related to the side effects of the study medications (cephalexin or clindamycin).
|
|||
Current Other Pre-specified Outcome Measures | Not Provided | |||
Original Other Pre-specified Outcome Measures | Not Provided | |||
Descriptive Information | ||||
Brief Title ICMJE | Antibiotic Prophylaxis for Simple Hand Lacerations | |||
Official Title ICMJE | Antibiotic Prophylaxis for Prevention of Infection in Emergency Department Patients With Simple Hand Lacerations | |||
Brief Summary | Research Question: In emergency department patients with simple hand cuts, do prophylactic antibiotics reduce the risk of wound infections? | |||
Detailed Description | Simple hand lacerations, defined as hand lacerations that do not involve special structures such as bones, tendons, vessels, or nerves, are common in the emergency departments. The exact rate of infection in such wounds is unclear. It is also not clear whether prescribing prophylactic antibiotics reduces the risk of infection in simple hand lacerations. The objective of this randomized double blind controlled study is to: 1. Identify the rate of infection in simple hand lacerations, 2. Identify factors or wound characteristics that increase the risk of infection, and 3. Assess whether prescribing prophylactic antibiotics decreases the risk of infections in such wounds compared to placebo. | |||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Not Applicable | |||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
|||
Condition ICMJE | Simple Hand Lacerations | |||
Intervention ICMJE |
|
|||
Study Arms ICMJE |
|
|||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
Recruitment Information | ||||
Recruitment Status ICMJE | Terminated | |||
Actual Enrollment ICMJE |
73 | |||
Original Estimated Enrollment ICMJE |
300 | |||
Actual Study Completion Date ICMJE | February 2012 | |||
Actual Primary Completion Date | February 2012 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
|||
Sex/Gender ICMJE |
|
|||
Ages ICMJE | 18 Years and older (Adult, Older Adult) | |||
Accepts Healthy Volunteers ICMJE | No | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | United States | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number ICMJE | NCT01155154 | |||
Other Study ID Numbers ICMJE | 09-130 | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | Shahriar Zehtabchi, State University of New York - Downstate Medical Center | |||
Study Sponsor ICMJE | State University of New York - Downstate Medical Center | |||
Collaborators ICMJE |
|
|||
Investigators ICMJE |
|
|||
PRS Account | State University of New York - Downstate Medical Center | |||
Verification Date | November 2014 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |